Duaklir Pressair and Flunisolide eent

• Generic Name: aclidinium / formoterol
• Dosage Forms: n.a.
• Other Brand Names: Duaklir Pressair

Duaklir Pressair contains a combination of aclidinium and formoterol and is supplied as a breath activated multi-dose dry powder inhaler.

Duaklir Pressair is a prescription medicine used to prevent airflow obstruction and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema.

Duaklir Pressair is for use only in people with COPD and should not be used to treat asthma.

• Generic Name: flunisolide nasal
• Dosage Forms: n.a.
• Other Brand Names:

  Nasalide, Nasarel

Symptomatic treatment of seasonal or perennial rhinitis when conventional therapy with antihistamines or decongestants is ineffective or produces intolerable adverse effects.

Generally provides symptomatic relief of watery rhinorrhea, nasal congestion, sneezing, postnasal drip, and pharyngeal itching; generally does not relieve symptoms of conjunctivitis or those involving the lower respiratory tract.

Appears to provide greater symptomatic relief in allergic rhinitis than in nonallergic rhinitis.

Serious Otitis Media

Has been used intranasally for the treatment of serous otitis media (eustachian tube dysfunction, middle ear effusion) in children.

Corticosteroid-dependent Asthma

Although orally inhaled flunisolide is used for the treatment of asthma, the nasal solution is not recommended for this purpose, since the safety of polyethylene glycol in the vehicle of the nasal solution has not been established for this route of administration.